Disease Burden

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null

Disease burden at start of bridging chemotherapy (high vs low), disease burden prior to lymphodepleting chemotherapy (high vs low), and tumor debulking by bridging chemotherapy did not significantly a

Effect: null